Share

Export Citation

APA
MLA
Chicago
Harvard
Vancouver
BIBTEX
RIS
Universitas Hasanuddin
Research output:Contribution to journalArticlepeer-review

Claudin-4 Expression as a Prognostic Biomarker in Colorectal Adenocarcinoma: Correlation with Lymphovascular Invasion, Lymph Node Metastasis, and Pathological Stage

Puspitasari R.E.

Trends in Sciences

Q2
Published: 2026

Abstract

Colorectal cancer (CRC) remains a leading cause of cancer mortality worldwide, with increasing incidence in Asia, including Indonesia. Claudin-4, a tight junction protein, plays a paradoxical role in epithelial barrier function and tumor progression. This study aimed to investigate the relationship between Claudin-4 expression and major prognostic parameters in colorectal adenocarcinoma. A total of 104 formalin-fixed paraffin-embedded tissue blocks of colorectal adenocarcinoma were analyzed immunohistochemically. Claudin-4 expression was categorized as strong (79.8%) or weak (20.2%) based on the Total Immunostaining Score (TIS). Statistical analysis revealed no significant association between Claudin-4 expression and age, sex, tumor location, or size. However, Claudin-4 expression was significantly negatively correlated with lymphovascular invasion (p = 0.020; OR = 0.314, 95% CI 0.114 - 0.861), lymph node metastasis (p = 0.011; OR = 0.283, 95% CI 0.103 - 0.778), and pathological stage (p = 0.028). No significant correlation was observed with distant metastasis. These findings suggest that Claudin-4 may serve as a prognostic biomarker reflecting tumor invasiveness, supporting its potential role in guiding risk stratification in CRC patients. HIGHLIGHTS Most colorectal adenocarcinoma cases (79.8%) showed strong Claudin-4 expression by immunohistochemistry. Low Claudin-4 expression was significantly linked to lymphovascular invasion and lymph node metastasis. Strong Claudin-4 expression was more common in early pathological stages, while advanced stages showed reduced expression. This study provides the first evidence from Indonesia on the prognostic role of Claudin-4 in colorectal adenocarcinoma. Findings support Claudin-4 as a promising biomarker to improve risk stratification in colorectal cancer patients. GRAPHICAL ABSTRACT

Access to Document

10.48048/tis.2026.11956

Other files and links

Fingerprint

Colorectal cancerSciences
MedicineSciences
Lymphovascular invasionSciences
PathologicalSciences
OncologySciences
BiomarkerSciences
Stage (stratigraphy)Sciences
Internal medicineSciences
Lymph nodeSciences
ImmunostainingSciences
AdenocarcinomaSciences
ImmunohistochemistrySciences
CorrelationSciences
Colorectal adenocarcinomaSciences
PathologySciences
CancerSciences
MetastasisSciences
Lymph node metastasisSciences
Distant metastasisSciences
Tumor buddingSciences
T-stageSciences
microRNASciences
Incidence (geometry)Sciences
Survival analysisSciences
Risk stratificationSciences
Lymphatic systemSciences
CarcinogenesisSciences
Tissue microarraySciences
DiseaseSciences